Holding(s) in Company
April 01 2008 - 8:42AM
UK Regulatory
RNS Number:3102R
EiRx Therapeutics PLC
01 April 2008
Financial Services Authority
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of Eirx Therapeutics Plc
existing shares to which voting rights are attached:
2. Reason for notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights X
Other (please specify):
3. Full name of person(s) subject to the notification Barclays PLC
obligation:
4. Full name of shareholder(s) (if different from 3):
Barclays Stockbrokers Ltd
5. Date of transaction and date on which the threshold is 19-Mar-08
crossed or reached:
6. Date on which issuer notified: 01-Apr-08
7. Threshold(s) that is/are crossed or reached: 13% to 11%
8. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to the Resulting situation after the triggering transaction
shares Triggering transaction
Number of Number of Number of Number of Voting % of voting rights
Shares Voting Rights Shares Rights
If possible use
ISIN code Direct Indirect Direct Indirect
GB00B0XQBS97 939,660,264 939,660,264 806,354,570 0 806,354,570 0.00 11.56
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting
instrument period/date that may be acquired rights
(if the instrument
exercised/converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
806,354,570 11.56
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: N/A
14. Contact name: Geoff Smith
15. Contact telephone number 020 7116 2913
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAOURWWRSRAR
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Oct 2023 to Oct 2024